{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:17Z","timestamp":1786119677358,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mjt.0b013e3182068cc6","type":"journal-article","created":{"date-parts":[[2010,12,31]],"date-time":"2010-12-31T12:28:41Z","timestamp":1293798521000},"page":"38-44","source":"Crossref","is-referenced-by-count":2,"title":["A New Estradiol-Dienogest Oral Contraceptive Marks \u201cThe Pill's\u201d 50th Anniversary"],"prefix":"10.1097","volume":"18","author":[{"given":"Lisa M","family":"Keder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210202","first-page":"40","article-title":"Love, sex, freedom and the paradox of the pill.","volume":"175","author":"Gibbs","year":"2010","journal-title":"Time"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00508-009-1280-x","article-title":"Ludwig Haberlandt-A pioneer in hormonal contraception.","volume":"121","author":"Haberlandt","year":"2009","journal-title":"Wien Kin Wochenschr"},{"key":"R8-8-20210202","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000301641","article-title":"The early history of progesterone.","volume":"5","author":"Corner","year":"1974","journal-title":"Gynecol Invest"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.02.020","article-title":"Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins.","volume":"78","author":"Goldzieher","year":"2008","journal-title":"Contraception"},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0378-5122(82)90064-0","article-title":"Pharmacokinetic and pharmacological features of oestradiol valerate.","volume":"4","author":"Dusterberg","year":"1982","journal-title":"Maturitas"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/0002-9378(82)90218-6","article-title":"Comparison of pharmacodynamic properties of various estrogen formulations.","volume":"144","author":"Mashchak","year":"1982","journal-title":"Am J Obstet Gynecol"},{"key":"R14-8-20210202","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0038-1646528","article-title":"A comparison between effects of estradiol valerate and low dose ethinyl estradiol on haemostasis parameters.","volume":"61","author":"Lindberg","year":"1989","journal-title":"Thromb Haemost"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.contraception.2009.08.010","article-title":"Review of clinical experience with estradiol in combined oral contraceptives.","volume":"81","author":"Fruzzetti","year":"2010","journal-title":"Contraception"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(80)90010-4","article-title":"A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens.","volume":"21","year":"1980","journal-title":"Contraception"},{"key":"R17-8-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-5122(88)90023-0","article-title":"New natural oestradiol\/cyproterone acetate oral contraceptive for pre-menopausal women.","volume":"10","author":"Hirvonen","year":"1988","journal-title":"Maturitas"},{"key":"R19-8-20210202","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/13625189909085259","article-title":"The pharmacological profile of dienogest.","volume":"4S","author":"Oettel","year":"1999","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R20-8-20210202","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.steroids.2007.10.003","article-title":"Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile.","volume":"73","author":"Sasagawa","year":"2008","journal-title":"Steroids"},{"key":"R21-8-20210202","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/humupd\/dmi019","article-title":"Noncontraceptive health benefits of combined oral contraception.","volume":"11","year":"2005","journal-title":"Hum Reprod Update"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.10696","article-title":"Long-term effects of oral contraceptives on ovarian cancer risk.","volume":"102","author":"Bossetti","year":"2002","journal-title":"Int J Cancer"},{"key":"R23-8-20210202","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00053128","article-title":"Oral contraceptive and the risk of endometrial cancer.","volume":"2","author":"Levi","year":"1991","journal-title":"Cancer Causes Conrol"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1001\/jama.292.6.726","article-title":"Treatment of acne vulgaris.","volume":"292","author":"Hader","year":"2004","journal-title":"JAMA"},{"key":"R25-8-20210202","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-0030-1248139","article-title":"Recent innovations in oral contraception.","volume":"28","author":"Cremer","year":"2010","journal-title":"Semin Reprod Med"},{"key":"R26-8-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/13625180902850039","article-title":"Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.","volume":"14","author":"Zeun","year":"2009","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R27-8-20210202","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.contraception.2008.05.004","article-title":"Ovulation inhibition with four variations of a four-phasic estradiol valerate\/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.","volume":"78","author":"Endrikat","year":"2008","journal-title":"Contraception"},{"key":"R28-8-20210202","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.contraception.2009.03.018","article-title":"Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate\/dienogest and ethinyl estradiol\/levonorgestrel.","volume":"80","author":"Ahrendt","year":"2009","journal-title":"Contraception"},{"key":"R29-8-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejogrb.2009.11.001","article-title":"Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate\/dienogest): a phase III trial.","volume":"149","author":"Palacios","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R31-8-20210202","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/14656561003724713","article-title":"Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest.","volume":"11","author":"Jensen","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"R32-8-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/13625180903427675","article-title":"Efficacy of contraceptive methods: a review of the literature.","volume":"15","author":"Mansour","year":"2010","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R33-8-20210202","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.contraception.2007.09.013","article-title":"Estimates of contraceptive failure from the 2002 National Survey of Family Growth.","volume":"77","author":"Kost","year":"2008","journal-title":"Contraception"},{"key":"R34-8-20210202","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.AOG.0000260956.61835.6d","article-title":"Oral contraceptive tolerance: does the type of pill matter?","volume":"109","author":"Moreau","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R35-8-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(95)00074-K","article-title":"Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation.","volume":"51","author":"Rosenberg","year":"1995","journal-title":"Contraception"},{"key":"R36-8-20210202","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel.","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"R37-8-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0010-7824(01)00221-9","article-title":"Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 g ethinylestradiol\/100 g levonorgestrel and 20 g ethinylestradiol\/500 g norethisterone.","volume":"64","author":"Endrikat","year":"2001","journal-title":"Contraception"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00045391-201101000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:49:02Z","timestamp":1786042142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00045391-201101000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182068cc6","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}